FIELD: medicine. SUBSTANCE: method involves administering a combination of progestin and nitrogen oxide synthase substratum, nitrogen oxide donor or both. The combination is optionally administered with one or several cyclo-oxigenase inhibitors, PGIPGI2-mimetic, thromboxan inhibitor (TXATXA2), a substance possessing TXATXA2-agonist properties, TXATXA2-inhibitor properties, a substance possessing TXATXA2- antagonist properties and PGIPGI2-mimetic activity, and TXATXA2- antagonist substance. EFFECT: enhanced effectiveness of treatment. 22 cl, 6 dwg, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF DONORS OF NITROGEN OXIDE OR INHIBITORS OF NITROGEN OXIDE FOR REGULATION OF UTERUS CERVIX OPENING AND STRETCHING | 1996 |
|
RU2199346C2 |
| ESTROGEN (PROGESTIN)-ANITOPROGESTIN METHOD OF PERORAL CONTRACEPTION AND MENSTRUATION CONTROL, PHARMACEUTICAL COMPOSITION, AND ASSEMBLY OF DRUGS | 1993 |
|
RU2127112C1 |
| PROGESTERONE ANTAGONISTS FOR PREPARING DRUGS USED IN TREATMENT OF PATIENTS WITH DISFUNCTIONAL UTERINE BLEEDING | 1995 |
|
RU2170580C2 |
| METHOD OF TUMOR METASTASIS TREATMENT | 1990 |
|
RU2112514C1 |
| ORAL CONTRACEPTIVES FOR PREVENTION PREGNANCY AND REDUCTION OF PREMENSTRUAL SYMPTOMATOLOGY | 2002 |
|
RU2351339C2 |
| USE OF COMPETITIVE PROGESTERONE ANTAGONISTS FOR CONTRACEPTION, NEW COMPOUNDS OF ORDER OF COMPETITIVE PROGESTERONE ANTAGONISTS | 1993 |
|
RU2137476C1 |
| METHOD OF TREATING THREATENED MISCARRIAGE IN EARLY PREGNANCY | 2009 |
|
RU2393841C1 |
| METHOD OF CORRECTING ENDOTHELIAL DYSFUNCTION BY L-NORVALIN IN CASE OF ADMA-LIKE MODEL OF GESTOSIS | 2010 |
|
RU2449381C1 |
| PROGESTERON FOR TREATMENT AND PREVENTION OF SPONTANEOUS PRETERM BIRTH | 2008 |
|
RU2524617C2 |
| METHOD FOR PREVENTING CHRONIC HYPOXIA AND FOETAL DEVELOPMENT RETARDATION | 2018 |
|
RU2699559C2 |
